You’re cruising through a lysosomal storage disease question, you recognize “angiokeratomas,” and you lock in the diagnosis—then you miss the point because you didn’t interrogate the distractors. On USMLE, the answer choices are often a curated mini-lesson: each option is there because it maps to a similar-looking vignette, a common confusion, or a mechanistic step you’re expected to know cold.
Tag: Biochemistry > Lysosomal & Glycogen Storage Diseases
The Vignette (Fabry Disease)
A 17-year-old boy presents with episodic burning pain in his hands and feet that worsens with exercise and heat. He reports decreased sweating. Exam shows clusters of dark red-purple papules over his lower trunk and groin. Urinalysis reveals proteinuria. Family history is notable for a maternal uncle who developed kidney failure in his 40s.
Question: The patient’s condition is most directly caused by deficiency of which enzyme?
The Correct Answer: α-Galactosidase A deficiency (Fabry disease)
Why it fits
Fabry disease is an X-linked recessive lysosomal storage disease due to deficiency of α-galactosidase A, leading to accumulation of globotriaosylceramide (ceramide trihexoside, Gb3) in endothelial cells, smooth muscle, renal cells, and nerves.
Classic clue cluster (memorize this combo)
- Neuropathic pain: acroparesthesias (burning pain in hands/feet)
- Angiokeratomas: “bathing suit” distribution (groin, hips, lower trunk)
- Hypohidrosis/anhidrosis: decreased sweating, heat intolerance
- Renal disease: proteinuria → progressive CKD/ESRD
- Cardiac: LVH, arrhythmias
- Eye: corneal verticillata (whorled corneal opacities)
Pathology + mechanism (the Step-friendly version)
- Lysosomal accumulation of Gb3 → vascular endothelial dysfunction + ischemia
- Small fiber neuropathy → pain crises
- Progressive renal and cardiac involvement drive morbidity/mortality
Diagnosis & management pearls (high yield)
- Low α-galactosidase A activity in males is diagnostic (females can have normal levels due to lyonization—genetic testing helps).
- Treatment:
- Enzyme replacement therapy (agalsidase)
- Chaperone therapy for select mutations (migalastat)
- Supportive: ACEi/ARB for proteinuria, renal/cardiac management
Q-Bank Skill: Why Every Distractor Matters
Below is how common answer choices map to similar vignettes—and how to rule them out fast.
Quick comparison table (Fabry vs common look-alikes)
| Disease | Enzyme defect | Inheritance | Storage material | Hallmark clues |
|---|---|---|---|---|
| Fabry | α-galactosidase A | XLR | Gb3 (ceramide trihexoside) | Angiokeratomas, acroparesthesias, hypohidrosis, renal failure |
| Gaucher | β-glucocerebrosidase | AR | Glucocerebroside | Hepatosplenomegaly, bone pain/crises, “crumpled tissue paper” macrophages |
| Tay-Sachs | Hexosaminidase A | AR | GM2 ganglioside | Neurodegeneration, cherry-red macula, no hepatosplenomegaly |
| Niemann-Pick | Sphingomyelinase | AR | Sphingomyelin | Neurodegeneration + hepatosplenomegaly, cherry-red macula, foam cells |
| Pompe | Acid α-glucosidase | AR | Glycogen (lysosomes) | Cardiomegaly, hypertrophic cardiomyopathy, hypotonia |
| von Gierke | Glucose-6-phosphatase | AR | Glycogen (liver) | Severe fasting hypoglycemia, lactic acidosis, hyperuricemia, hyperlipidemia |
Distractor Walkthrough (Option-by-option)
Distractor 1: β-glucocerebrosidase deficiency (Gaucher disease)
Why they tempt you: Gaucher is the most common lysosomal storage disease and can show organ involvement.
Why it’s wrong here:
- Gaucher screams hepatosplenomegaly + cytopenias + bone pain
- The vignette screams neuropathic pain + angiokeratomas + hypohidrosis
- Gaucher classically has:
- “Crumpled tissue paper” macrophages in bone marrow
- Erlenmeyer flask deformity (radiology buzzword)
High-yield trap: Don’t confuse Fabry’s pain crises (neuropathic) with Gaucher’s bone crises (skeletal).
Distractor 2: Hexosaminidase A deficiency (Tay-Sachs)
Why they tempt you: Neuro symptoms show up in multiple storage diseases, and “X-linked vs AR” is a frequent test angle.
Why it’s wrong here:
- Tay-Sachs features:
- Progressive neurodegeneration
- Cherry-red macula
- No hepatosplenomegaly
- But it does not give you:
- Angiokeratomas
- Hypohidrosis
- Renal failure/proteinuria as a key presenting feature
- Also: Tay-Sachs is infantile onset in classic cases, not teen-onset pain crises.
High-yield association: Tay-Sachs: GM2 accumulation in neurons → neuro decline; Fabry: Gb3 in endothelium → pain, skin, kidney, heart.
Distractor 3: Sphingomyelinase deficiency (Niemann-Pick disease)
Why they tempt you: Also a sphingolipid-related lysosomal storage disease; can have neuro involvement and cherry-red spot.
Why it’s wrong here:
- Niemann-Pick classically includes:
- Hepatosplenomegaly
- Neurodegeneration
- Foam cells (lipid-laden macrophages)
- Fabry is more vascular/renal/cardiac + dermatologic:
- Angiokeratomas
- Neuropathic pain
- Hypohidrosis
Fast elimination: If the stem is heavy on organomegaly, think Niemann-Pick/Gaucher; if it’s heavy on pain + angiokeratomas, think Fabry.
Distractor 4: Acid α-glucosidase deficiency (Pompe disease)
Why they tempt you: It’s a storage disease and shows up in the same “lysosomal & glycogen” unit.
Why it’s wrong here:
- Pompe = glycogen in lysosomes, especially muscle
- Classic infantile Pompe:
- Cardiomegaly / hypertrophic cardiomyopathy
- Hypotonia (“floppy baby”)
- Macroglossia
- Our patient has:
- Skin lesions (angiokeratomas)
- Neuropathic pain
- Renal proteinuria
High-yield mnemonic vibe: Pompe is a muscle/heart story; Fabry is an endothelium/kidney/skin/nerve story.
Distractor 5: Glucose-6-phosphatase deficiency (von Gierke disease)
Why they tempt you: “Storage disease” plus kidney involvement can lure you; also a favorite for biochem labs.
Why it’s wrong here:
- von Gierke is a glycogen storage disease (GSD I)—not primarily lysosomal—and presents with severe metabolic derangements:
- Severe fasting hypoglycemia
- Lactic acidosis
- Hyperuricemia
- Hyperlipidemia
- Hepatomegaly/renomegaly
- The vignette is not about hypoglycemia; it’s about vascular/neuropathic symptoms and angiokeratomas.
Test-taking move: If the labs in the stem scream metabolic catastrophe, think hepatic glycogen storage diseases; if the stem screams “weird lipids in lysosomes,” think sphingolipidoses.
Fabry Disease: Micro–High Yield Checklist
Must-know facts for Step 1/2
- Inheritance: X-linked recessive
- Enzyme: α-galactosidase A
- Substrate: Gb3 (ceramide trihexoside)
- Key symptoms: acroparesthesias, angiokeratomas, hypohidrosis, renal failure, cardiac disease
- Important nuance: females can be symptomatic (variable expression due to X-inactivation)
Clinical correlates you can be tested on
- Renal: proteinuria is an early clue → progressive CKD
- Cardiac: LVH, arrhythmia, ischemic disease
- Neuro: stroke/TIA risk can be increased due to vascular involvement
How This Question Gets Harder on Test Day
USMLE likes to swap one clue and see if you still anchor correctly:
- If they emphasize hepatosplenomegaly + bone pain: pivot to Gaucher
- If they emphasize infant neuro decline + cherry-red macula + no HSM: pivot to Tay-Sachs
- If they emphasize HSM + foam cells ± cherry-red macula: pivot to Niemann-Pick
- If they emphasize cardiomegaly + hypotonia in an infant: pivot to Pompe
- If they emphasize fasting hypoglycemia + lactic acidosis: pivot to von Gierke
Takeaway: The “One-Liner” You Should Be Able to Say
Fabry disease = X-linked α-galactosidase A deficiency → Gb3 accumulation → angiokeratomas + acroparesthesias + hypohidrosis + progressive renal/cardiac disease.